Bracco Diagnostics Unveils Max 3 Injector with FDA Approval for MRI Innovations

Bracco Diagnostics Introduces Game-Changing Max 3™ Injector

Bracco Diagnostics Inc. has recently achieved a significant milestone with the FDA's clearance of its groundbreaking product, the Max 3™, a Rapid Exchange and Syringeless Injector designed for Magnetic Resonance Imaging (MRI) procedures. This innovative device not only enhances efficiency but also paves the way for sustainable practices in the healthcare industry.

A New Standard in MRI Technology

The Max 3™ is the first of its kind in the MRI sector, offering a user-friendly experience with remarkable features that redefine how MRI procedures are conducted. One of its standout functionalities is the ability to inject directly from original contrast media vials without the need for syringe refilling. This not only saves time but also allows healthcare providers to position the injector anywhere within an MRI room, as it operates without cumbersome power cables. The device can handle magnetic field strengths of up to 50mT, making it versatile and adaptable to different environments.

Additionally, the Max 3™ employs an Easy-Click-Cassette flex that includes a dedicated connector to patient tubing, ensuring safe and reliable injections while minimizing the risk of contamination. This feature allows the device to be effectively utilized for a maximum of 24 hours or with up to 96 bottles of contrast media, further streamlining the workflow in radiology departments.

Commitment to Sustainability

In line with modern healthcare demands, Bracco Diagnostics emphasizes sustainability through its new product. The Max 3™ injector significantly reduces plastic waste compared to traditional syringes, thus contributing to eco-friendly initiatives in hospitals. Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging S.p.A, expresses the company's dedication to innovation and environmental stewardship, asserting that the Max 3™ is a key element in advancing patient care standards for the future.

Partnership for Progress

This latest innovation is a result of a strategic partnership with ulrich GmbH & Co. KG, a respected German medical device manufacturer specializing in contrast media injectors and spinal implants. Klaus Kiesel, CEO of ulrich medical, remarked on the shared vision of enhancing the quality of healthcare through intuitive, user-friendly, and environmentally responsible solutions.

Recognition for Design Excellence

Notably, the innovative design of the Max 3™ has earned it a Red Dot Design Award, acknowledging its exceptional product design and functionality. This accolade solidifies Bracco Diagnostics’ commitment to excellence in the field of diagnostic imaging and reinforces its position as a trusted partner for the radiology community.

The Future of MRI with Bracco Diagnostics

With the launch of the Max 3™, Bracco Diagnostics is set to redefine the standards of patient care and improve workflows in clinical settings. Cosimo De Pinto, Senior Vice President of Sales and Marketing at Bracco Diagnostics Inc., highlights the importance of this product in delivering comprehensive MRI solutions that meet the evolving needs of healthcare providers. As the company moves forward, it remains dedicated to integrating advanced technology with sustainable practices, ensuring better healthcare outcomes.

For more information about the Max 3™ and its contributions to MRI procedures, visit Bracco's official page.